United Microelectronics Co (UMC, 聯電), the world’s No. 3 contract chipmaker, yesterday said it would not consider rejoining the race to develop 7-nanometer (nm) technology after bigger rival GlobalFoundries Inc abandoned a plan to invest in it.
UMC in July last year said that it would not allocate capital for process technologies below 14 nanometers as it restructured to focus on boosting returns on investments.
The Hsinchu-based chipmaker said at the time that “it is difficult to address the 10-nanometer or 7-nanometer markets,” citing a smaller market size compared with less-advanced, but matured, technologies.
The company said its growth would come from end demand for Internet of Things and automotive applications, which do not required advanced chips.
When asked whether UMC would change its mind and redirect resources toward developing 7-nanometer technology, UMC co-president Chien Shan-chieh (簡山傑) said: “No, we won’t.”
Semiconductor companies face challenges to push technological boundaries because of costs and development hurdles, Chien said.
That is probably part of GlobalFoundries’ decision to halt development of 7-nanometer technology, he said.
Supply and demand imbalances, as well as a persistent shortage of silicon substrate are also challenges for chipmakers, he said.
Chipmakers have seen their 8-inch fabs under supply constraint, while 12-inch fabs have a supply surplus, he said.
“Our 14-nanometer [technology] is fully utilized currently. We have small 14-nanometer capacity,” Chien said. “Our 8-inch fabs are fully utilized” as well.
UMC declined to provide further information about its 14-nanometer technology, given its limited customer base.
The company in the second quarter last year had installed capacity to produce 2,000 12-inch wafers per month.
The chipmaker began shipping 14 nanometer chips, the most advanced technology offered by UMC, to clients in the second quarter of last year.
UMC said 14-nanometer technology contributed 3 percent of its revenue, which totaled NT$38.85 billion (US$1.27 billion) last quarter, up from 2 percent in the prior quarter and 1 percent a year earlier.
While 28-nanometer technology was the firm’s largest source of revenue, accounting for 26 percent last quarter, it was down from 30 percent in the first quarter due to sagging demand.
“UMC’s strategy is very clear. It is good, as the company focuses on more mature technologies, which deliver a higher gross margin,” Clark Tseng (曾瑞榆), director of the industry research and statistics unit of SEMI Taiwan, told reporters on the sidelines of a news conference in Taipei.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and Samsung Electronics Co are likely to be the main suppliers of 7-nanometer technology on a contract basis, Tseng said.
TSMC has led its rivals in ramping up 7-nanometer technology in the second quarter of this year.
China’s Semiconductor Manufacturing International Corp (中芯) has said it plans to invest in 7-nanometer technology, but it would lag far behind TSMC and Samsung for at least four or five years in offering such advanced technology, Tseng said.
Taiwan’s semiconductor industry is forecast to grow production value by 6 percent year-on-year to NT$2.61 trillion this year, Tseng said.
Next year, the growth rate is likely to accelerate to 8 percent and fall back to 6 percent in 2020 and 2021, or about NT$3 trillion, he said.
The rise of the cryptocurrency dogecoin has reached a new level after the token was used to pay for a lunar satellite launch. SpaceX, Elon Musk’s commercial rocket firm, is to embark on a moon voyage next year carrying a so-called cubesat — a mini-satellite used for space research — from Geometric Energy Corp that has been paid for entirely in dogecoin. The development is the latest twist in the saga over the digital token, which started as a joke in 2013, but is now a dominating Internet meme and sitting on a 21,000 percent rally in the past year. Musk has
CAPACITY EXPANSION: Construction of the site, which is to be the firm’s first mRNA production facility outside of Europe, is to begin this year and likely finish in 2023 COVID-19 vaccine maker BioNTech SE yesterday said it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of messenger RNA (mRNA)-based vaccines per year. Construction of the site would start this year, and it could become operational by 2023, the German company said in a statement. “With this planned mRNA production facility, we will increase our overall network capacity, and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world,” BioNTech chief executive Ugur Sahin said. The vaccine produced by BioNTech jointly with Pfizer Inc of
OUTBREAK: About 200 of the airline’s 1,200 pilots are not able to work. Most of them have been quarantined to prevent further infection, but 12 have COVID-19 China Airlines Ltd (CAL,中華航空) yesterday confirmed that it would temporarily reduce its cargo flight services to cope with a pilot shortage, as one-sixth of its pilots have been sidelined by a COVID-19 outbreak. “We are working out a new schedule,” the airline said in a statement after local news media reports on Saturday said that it would be reducing its cargo services from Wednesday, primarily affecting US destinations. CAL declined to give details about its new operating plan, but the reports said that it would be suspending its cargo flights to Dallas Fort Worth International Airport, Hartsfield-Jackson Atlanta International Airport and
The Financial Supervisory Commission (FSC) yesterday fined Citibank Taiwan Ltd (花旗台灣) NT$10 million (US$357,194) and DBS Bank Taiwan (星展台灣) NT$6 million for breaches of the nation’s anti-money laundering (AML) regulations. The NT$10 million fine is the highest penalty that it has imposed on a domestic bank, the commission said. Citibank Taiwan failed to set up a sound mechanism for evaluating clients’ risk of money laundering and for detecting suspicious transactions, Banking Bureau Deputy Director-General Huang Kuang-hsi (黃光熙) told a news conference in New Taipei City. The bank based its AML policies on those of its US-based parent company, Citigroup Inc, but the policies